Haemonetics HAE Ratios (2009-2026)

NYSE HAE
$100.99 -2.18 (-2.11%)
As of: Sep 10, 2026 · 2:44 PM EDT
Reported Financials

Haemonetics Quarterly Ratios

Periods 69 quarters
Latest Jun 2026

Haemonetics reported a gross margin of 59.76% and a net margin of 9.72% for the quarter ended Jun 2026. These financial ratios cover 69 quarters of results from Jun 2009 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Jun2009 Sep2009 Dec2009 Apr2010 Jul2010 Oct2010 Jan2011 Apr2011 Jul2011 Oct2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Apr2016 Jul2016 Oct2016 Dec2016 Apr2017 Jul2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Apr2021 Jul2021 Oct2021 Jan2022 Apr2022 Jul2022 Oct2022 Dec2022 Apr2023 Jul2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
51.08%53.34%51.44%54.41%53.07%51.98%51.33%53.73%53.59%52.90%51.24%52.03%54.25%55.53%58.39%59.82%59.50%59.71%57.23%59.76%
EBT Margin
8.30%12.08%5.78%9.75%13.80%13.83%10.72%16.57%10.32%13.09%6.82%13.90%12.94%14.32%21.40%14.05%15.67%17.69%-8.20%14.02%
EBIT Margin
10.22%13.72%7.24%11.77%15.71%14.18%11.58%17.24%11.10%13.67%8.72%11.83%14.96%16.94%21.58%16.76%17.87%19.88%-6.65%16.93%
EBITDA Margin
10.22%13.72%7.24%11.77%15.71%14.18%11.58%17.24%11.10%13.67%8.72%11.83%14.96%16.94%21.58%16.76%17.87%19.88%-6.65%16.93%
Operating Margin
10.22%13.72%7.24%11.77%15.71%14.18%11.58%17.24%11.10%13.67%8.72%11.83%14.96%16.94%21.58%16.76%17.87%19.88%-6.65%16.93%
Net Margin
6.18%8.93%3.69%7.60%11.15%10.78%9.67%13.18%7.83%9.29%5.94%11.41%9.78%10.76%17.54%10.59%11.82%13.20%-5.81%9.72%
FCF Margin
9.44%13.77%12.43%-1.33%17.17%15.58%-4.42%3.66%28.29%-4.52%16.72%-9.84%11.40%10.10%30.52%4.24%32.48%25.73%15.38%13.09%
Efficiency
Inventory AverageInventory Avg.
324.58M314.20M299.38M285.46M266.28M255.22M257.57M274.29M287.52M294.93M310.61M345.49M377.95M370.86M362.38M362.83M348.37M328.70M313.78M306.55M
Assets AverageAssets Avg.
1,797.84M1,816.44M1,845.56M1,840.13M1,842.82M1,871.59M1,906.45M1,948.54M1,986.77M2,105.85M2,198.01M2,368.28M2,533.10M2,528.25M2,491.11M2,456.52M2,452.12M2,466.52M2,443.41M2,380.66M
Invested CapitalInvested Cap.
1,479.33M1,507.96M1,523.01M1,540.42M1,546.76M1,542.75M1,583.88M1,629.57M1,655.89M1,813.90M1,767.75M2,128.95M2,103.81M2,131.70M2,045.62M2,411.03M2,378.24M2,440.93M2,020.90M2,030.26M
Asset Utilization RatioAsset Util.
0.520.520.540.560.590.600.610.630.620.600.600.560.540.540.550.550.540.530.550.57
Leverage & Solvency
Interest Coverage RatioInterest Cover
Debt Ratio
0.430.420.420.420.440.410.400.390.380.400.370.480.490.480.500.620.630.610.510.50
Times Interest Earned
Valuation
Price to EarningsP/E
248.03116.91334.01173.80112.98120.50141.88105.19182.48139.06212.41110.28118.93103.9352.55104.4458.2184.03-121.54106.58
Price to SalesP/S
15.3210.4412.3213.2112.5913.0013.7113.8714.2912.9112.6312.5911.6411.189.2211.066.8811.097.0610.36
Price to BookP/B
5.263.714.364.485.145.115.104.995.094.604.524.674.574.303.714.032.654.123.074.20
Enterprise Value
3,483.91M2,474.05M3,004.79M3,239.62M3,505.13M3,743.46M3,890.15M4,031.37M4,194.32M4,148.65M4,155.94M3,887.45M3,721.13M3,575.89M2,740.00M3,261.22M1,955.40M3,396.09M2,200.01M3,291.09M
EV to EBIT
142.1469.40156.51105.3075.0086.50110.3475.13118.8190.23138.8097.7871.9860.5838.4160.5433.4350.39-95.5557.28
EV to EBITDA
142.1469.40156.51105.3075.0086.50110.3475.13118.8190.23138.8097.7871.9860.5838.4160.5433.4350.39-95.5557.28
Market Capitalization
3,676.33M2,710.93M3,264.28M3,454.57M3,746.33M3,967.46M4,174.61M4,317.09M4,545.32M4,342.63M4,334.74M4,231.88M4,020.41M3,896.73M3,046.76M3,554.11M2,251.82M3,759.45M2,445.45M3,514.48M
Price to FCFP/FCF
162.3275.7999.11-994.4173.3483.41-310.52378.5350.50-285.9675.52-127.94102.07110.6430.19260.5521.1843.1145.9079.12
EV to FCF
153.8369.1791.23-932.5368.6278.70-289.36353.4746.60-273.1972.41-117.5394.47101.5327.15239.0718.3938.9441.2974.10
EV to CFO
80.1639.6344.1677.1540.2758.1148.86211.2242.31-0.01M64.85-141.7776.2281.7023.51187.4817.5736.3031.0162.90
Return Ratios
Return on Sales [ROS]ROS
10.22%13.72%7.24%11.77%15.71%14.18%11.58%17.24%11.10%13.67%8.72%11.83%14.96%16.94%21.58%16.76%17.87%19.88%-6.65%16.93%
Return on Capital Employed [ROCE]ROCE
2.99%2.76%5.75%6.64%8.37%8.51%9.43%10.45%9.72%9.23%8.69%7.16%7.41%7.93%11.60%12.26%12.75%13.03%7.25%7.57%
Return on Invested Capital [ROIC]ROIC
3.56%2.91%3.63%5.28%6.51%6.99%8.14%9.08%8.21%7.71%7.13%6.06%6.16%6.73%8.40%8.21%7.85%8.05%5.34%5.84%
Return on Assets [ROA]ROA
1.74%1.24%2.35%3.68%4.67%5.12%6.05%7.01%6.46%6.01%5.35%4.85%4.89%5.14%6.73%6.65%6.86%7.11%3.98%4.04%